Patents/Assignees

Chromadex Inc.

5 patents in portfolio

US12558367utility2026
Nicotinamide Riboside and Derivatives Thereof in Intravenous Formulations and Methods of Use Thereof
0 cites
US12485134utility2025
Use of Nicotinamide Riboside, Nicotinic Acid Riboside, Reduced Nicotinyl Riboside Compounds, and Nicotinyl Riboside Compound Derivatives in Formulations
0 cites
US12433908utility2025
Use of Nicotinamide Riboside, Nicotinic Acid Riboside, and Nicotinamide Mononucleotide, Reduced Nicotinyl Compounds, and Nicotinoyl Compound Derivatives in Infant Formula for Healthy Development
0 cites
US12195494utility2025
Efficient and Scalable Syntheses of Nicotinoyl Ribosides and Reduced Nicotinoyl Ribosides, Modified Derivatives Thereof, Phosphorylated Analogs Thereof, Adenylyl Dinucleotide Conjugates Thereof, and Novel Crystalline Forms Thereof
0 cites
US11746123utility2023
Efficient and Scalable Syntheses of Nicotinoyl Ribosides and Reduced Nicotinoyl Ribosides, Modified Derivatives Thereof, Phosphorylated Analogs Thereof, Adenylyl Dinucleotide Conjugates Thereof, and Novel Crystalline Forms Thereof
0 cites